Assessing Cardiovascular Risk in Inflammatory Bowel Disease Using Novel Inflammatory and Dyslipidemia Markers: An Evaluation of PAI, MHO, and SII


Ağırbaş Çelen B., ERUZUN H., GÖKDEN Y.

Journal of Enterocolitis, cilt.4, sa.3, ss.55-60, 2025 (Hakemli Dergi) identifier